1 – 10 of 104
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
In-Depth Analysis of Disease Manifestations in Antineutrophil Cytoplasmic Antibody–Associated Vasculitides Identifies Distinct Clinical Phenotypes
(
- Contribution to journal › Article
-
Mark
Arterial and venous thrombosis in systemic and monogenic vasculitis
(
- Contribution to journal › Scientific review
-
Mark
Giant cells in temporal artery biopsies and the risk of large-vessel involvement in patients with giant cell arteritis
(
- Contribution to journal › Scientific review
-
Mark
Myocardial infarction in ANCA-associated vasculitis : A population-based cohort study
(
- Contribution to journal › Article
-
Mark
The use of intravenous methylprednisolone in giant cell arteritis : a population-based study
(
- Contribution to journal › Article
- 2024
-
Mark
EULAR recommendations for the management of ANCA-associated vasculitis : 2022 update
(
- Contribution to journal › Article
-
Mark
Apolipoproteins and the risk of giant cell arteritis—a nested case–control study
(
- Contribution to journal › Article
-
Mark
The HLA region in ANCA-associated vasculitis : characterisation of genetic associations in a Scandinavian patient population
(
- Contribution to journal › Article
-
Mark
Classification Criteria for ANCA Associated Vasculitis – Ready for Prime Time?
(
- Contribution to journal › Scientific review
-
Mark
Epidemiology and clinical characteristics of biopsy-confirmed adult-onset IgA vasculitis in southern Sweden
(
- Contribution to journal › Article